Cargando…

Return to play with hypertrophic cardiomyopathy: are we moving too fast? A critical review

The diagnosis of a potentially lethal cardiovascular disease in a young athlete presents a complex dilemma regarding athlete safety, patient autonomy, team or institutional risk tolerance and medical decision-making. Consensus cardiology recommendations previously supported the ‘blanket’ disqualific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drezner, Jonathan A, Malhotra, Aneil, Prutkin, Jordan M, Papadakis, Michael, Harmon, Kimberly G, Asif, Irfan M, Owens, David S, Marek, Joseph C, Sharma, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408577/ https://www.ncbi.nlm.nih.gov/pubmed/33472848 http://dx.doi.org/10.1136/bjsports-2020-102921

Ejemplares similares

Exercise and hypertrophic cardiomyopathy: Two incompatible entities?
por: Basu, Joyee, et al.
Publicado: (2020)

Never Too Old: A Nonagenarian With Apical Hypertrophic Cardiomyopathy
por: Ashraf, Muddasir, et al.
Publicado: (2023)

Simple electrocardiographic parameters predicting risk of hypertrophic cardiomyopathy: Too simple?
por: Çay, Serkan, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities?
por: Wilson, Mathew G, et al.
Publicado: (2011)

Performance of the American Heart Association (AHA) 14‐Point Evaluation Versus Electrocardiography for the Cardiovascular Screening of High School Athletes: A Prospective Study
por: Williams, Elizabeth A., et al.
Publicado: (2019)

Cerebral Microhemorrhages in a Collegiate Football Player: Clinical Implications in the Management of Sports Concussion
por: Asif, Irfan M., et al.
Publicado: (2010)

Cardiac Troponin Testing as a Component of Return to Play Cardiac Screening in Young Competitive Athletes Following SARS‐CoV‐2 Infection
por: Moulson, Nathaniel, et al.
Publicado: (2022)

Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy
por: Finocchiaro, Gherardo, et al.
Publicado: (2017)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Suicide in National Collegiate Athletic Association (NCAA) Athletes: A 9-Year Analysis of the NCAA Resolutions Database
por: Rao, Ashwin L., et al.
Publicado: (2015)

Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation
por: Augustine, Daniel X, et al.
Publicado: (2021)

Anterior Cruciate Ligament Rehabilitation and Return to Sport: How Fast Is Too Fast?
por: Waldron, Kristen, et al.
Publicado: (2022)

Exercise restrictions trigger psychological difficulty in active and athletic adults with hypertrophic cardiomyopathy
por: Luiten, Rebecca C, et al.
Publicado: (2016)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians
por: Wilson, Mathew G, et al.
Publicado: (2020)

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy
por: Packard, Elizabeth, et al.
Publicado: (2022)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy
por: Sivalokanathan, Sanjay
Publicado: (2022)

Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes
por: Baggish, Aaron, et al.
Publicado: (2020)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy masked by pericarditis
por: Nichols, Larry, et al.
Publicado: (2019)

Thromboembolism in Patients with Hypertrophic Cardiomyopathy
por: Liu, Lu, et al.
Publicado: (2021)

The natural history of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy with a Twist
por: Francis, W., et al.
Publicado: (2021)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6er16bs1q8e5c5lqlqpte3p89f